Ontology highlight
ABSTRACT: Background
Dementia is common in Parkinson's disease, but the underlying brain pathology is not yet fully understood.Aim
To examine the changes in the brain of patients with Parkinson's disease with mild cognitive impairment (MCI) and dementia, using structural magnetic resonance imaging.Methods
Using voxel-based morphometry, the grey matter atrophy on brain images of patients with Parkinson's disease and dementia (PDD; n = 16) and Parkinson's disease without dementia (PDND; n = 20), and healthy elderly subjects (n = 20) was studied. In the PDND group, 12 subjects had normal cognitive status and 8 had MCI. Standardised rating scales for motor, cognitive and psychiatric symptoms were used.Results
Widespread areas of cortical atrophy were found in patients with PDD compared with normal controls (in both temporal and frontal lobes and in the left parietal lobe). Grey matter reductions were found in frontal, parietal, limbic and temporal lobes in patients with PDD compared with those with PDND. In patients with PDND with MCI, areas of reduced grey matter in the left frontal and both temporal lobes were found.Conclusion
These findings show that dementia in Parkinson's disease is associated with structural neocortical changes in the brain, and that cognitive impairment in patients with PDND may be associated with structural changes in the brain. Further studies with larger groups of patients are needed to confirm these findings.
SUBMITTER: Beyer MK
PROVIDER: S-EPMC2117633 | biostudies-literature | 2007 Mar
REPOSITORIES: biostudies-literature
Beyer Mona K MK Janvin Carmen C CC Larsen Jan P JP Aarsland Dag D
Journal of neurology, neurosurgery, and psychiatry 20061006 3
<h4>Background</h4>Dementia is common in Parkinson's disease, but the underlying brain pathology is not yet fully understood.<h4>Aim</h4>To examine the changes in the brain of patients with Parkinson's disease with mild cognitive impairment (MCI) and dementia, using structural magnetic resonance imaging.<h4>Methods</h4>Using voxel-based morphometry, the grey matter atrophy on brain images of patients with Parkinson's disease and dementia (PDD; n = 16) and Parkinson's disease without dementia (PD ...[more]